Search Results - Ian Miller
- Showing 1 - 20 results of 40
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Performance of Commercial Dermatoscopic Systems That Incorporate Artificial Intelligence for the Identification of Melanoma in General Practice: A Systematic Review by Ian Miller, Nedeljka Rosić, Michael Stapelberg, Jeremy Hudson, P. Coxon, James Furness, Joe Walsh, Mike Climstein
Published 2024Revisão -
8
-
9
-
10
-
11
Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1,... by R. Edward Hogan, Daniel Tarquinio, Michael R. Sperling, Pavel Klein, Ian Miller, Eric Segal, Adrián L. Rabinowicz, Enrique Carrazana
Published 2020Artigo -
12
Localizing value of ictal <scp>SPECT</scp> is comparable to <scp>MRI</scp> and <scp>EEG</scp> in children with focal cortical dysplasia by Pavel Kršek, Martin Kudr, Alena Jahodová, Vladimı́r Komárek, Bruno Maton, Stephen M. Malone, Ian Miller, Prasanna Jayakar, Trevor Resnick, Michael Duchowny
Published 2013Artigo -
13
Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel by Elaine Wirrell, Linda Laux, Elizabeth Donner, Nathalie Jetté, Kelly G. Knupp, Mary Anne Meskis, Ian Miller, Joseph Sullivan, Michelle Welborn, Anne T. Berg
Published 2017Artigo -
14
-
15
-
16
Predictors of seizure‐free outcome after epilepsy surgery for pediatric tuberous sclerosis complex by Pavel Kršek, Alena Jahodová, Martin Kynčl, Martin Kudr, Vladimı́r Komárek, Petr Ježdík, Prasanna Jayakar, Ian Miller, Brandon Korman, Gustavo Rey, Trevor Resnick, Michael Duchowny
Published 2013Artigo -
17
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome by Ian Miller, Ingrid E. Scheffer, Boudewijn Gunning, Rocío Sánchez‐Carpintero, António Gil‐Nagel, Μ. Scott Perry, Russell P. Saneto, Daniel Checketts, Eduardo Dunayevich, Volker Knappertz
Published 2020Artigo -
18
C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase by Eun Kyoung Kim, Ian Miller, Susan Aja, Leslie E. Landree, Michael L. Pinn, Jill M. McFadden, Francis P. Kuhajda, Timothy H. Moran, Gabriele V. Ronnett
Published 2004Artigo -
19
Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial by Ingrid E. Scheffer, Jonathan J. Halford, Ian Miller, Rima Nabbout, Rocío Sánchez‐Carpintero, Yael Shiloh‐Malawsky, Matthew H. Wong, Marta Żołnowska, Daniel Checketts, Eduardo Dunayevich, Orrin Devinsky
Published 2021Artigo -
20
Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy by James W. Wheless, Dennis Dlugos, Ian Miller, D. Alexander Oh, Neha Parikh, Steven Phillips, J. Ben Renfroe, Colin Roberts, Isra Saeed, Steven Sparagana, Jin Yu, Maria Roberta Cilio
Published 2019Artigo
Search Tools:
Related Subjects
Medicine
Epilepsy
Internal medicine
Psychiatry
Anesthesia
Biology
Pathology
Psychology
Alternative medicine
Pediatrics
Placebo
Adverse effect
Cannabidiol
Cannabis
Dravet syndrome
Gene
Genetics
Neuroscience
Randomized controlled trial
Epilepsy surgery
Surgery
Computational biology
Disease
Ictal
Cell biology
Chemistry
Electroencephalography
Lennox–Gastaut syndrome
Neurostimulation
Stimulation